Abstract |
Post-kidney transplant erythrocytosis (PTE) is one of the hematological complications in the renal transplant patients. While its pathogenesis still remains to be elucidated completely, a number of therapies are available for the management of PTE. The aim of this prospective study was to investigate whether angiogenesis may be involved in the pathogenesis of post-transplant erythrocytosis by comparing its level with those of different classes of erythrocytosis [ polycythemia vera (PV), idiopathic erythrocytosis and secondary erythrocytosis]. The angiogenic activity was evaluated by the assessment of the serum vascular endothelial growth factor ( VEGF) levels, as one of circulating angiogenic factor, using a standardized enzyme-linked immunosorbent assay commercial kit in 13 PTE (2 F/11 M), in 75 untreated erythrocytosis non-transplant patients and in 21 healthy subjects controls. The results indicated that VEGF was overproduced in advanced and untreated PV patients and to a lesser degree in idiopathic erythrocytosis thus confirming an increased angiogenic activity. However, there is no evidence of increased angiogenesis in PTE and in secondary erythrocytosis. The absence of angiogenesis in PTE and its presence in PV is another argument that the pathogenesis of these two entities is different.
|
Authors | Chokri Maktouf, Soumaya Yaich, Sabra Aloui, Azza Bounemra, Khaled Charfeddine, Habib Skhiri, Jamil Hachicha |
Journal | Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
(Saudi J Kidney Dis Transpl)
Vol. 25
Issue 5
Pg. 1026-9
(Sep 2014)
ISSN: 1319-2442 [Print] Saudi Arabia |
PMID | 25193901
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Biomarkers
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
|
Topics |
- Biomarkers
(blood)
- Case-Control Studies
- Enzyme-Linked Immunosorbent Assay
- Humans
- Kidney Transplantation
(adverse effects)
- Polycythemia
(blood, diagnosis, etiology)
- Polycythemia Vera
(blood, etiology)
- Prospective Studies
- Up-Regulation
- Vascular Endothelial Growth Factor A
(blood)
|